Schedule 13G ownership disclosure

OPIANT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 683750103

Event date: 2018-09-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
199,368
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-18-000554
Form type
SC 13G
Filer
OPIANT PHARMACEUTICALS, INC.
CIK
CIK 1385508
Filed
Oct 09, 2018
Reporting period
Sep 26, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub